{
    "address": "Karolinska Institutet Science Park, Fogdevreten 2",
    "city": "Solna",
    "country": "SE",
    "currency": "SEK",
    "cusip": "W5S33J103",
    "description": "Lipidor AB is a drug development company. The company is headquartered in Solna, Stockholm. The company went IPO on 2019-09-27. The firm is focused to develop, patent and commercialize formulation concepts and technologies based on lipids. The firm develops product concepts based on AKVANO technology, which represents a dosage form that creates a lipid layer on the skin surface for effective delivery of drugs and skin care treatment. The Company\u2019s cooperation partners include Cerbios-Pharma, which specializes in the development and manufacturing of chemical and biological active pharmaceutical ingredients (APIs), and Aurena Laboratories AB, a manufacturer of bag-on-valve aerosol sprays for the pharmaceutical and medical device industry.",
    "employeeTotal": "",
    "exchange": "NASDAQ OMX NORDIC",
    "finnhubIndustry": "Pharmaceuticals",
    "ggroup": "Pharmaceuticals, Biotechnology & Life Sciences",
    "gind": "Pharmaceuticals",
    "gsector": "Health Care",
    "gsubind": "Pharmaceuticals",
    "ipo": "2019-09-27",
    "isin": "SE0012558617",
    "logo": "https://finnhub.io/api/logo?symbol=LIPI.ST",
    "marketCapitalization": 343.0341,
    "naics": "Pharmaceutical and Medicine Manufacturing",
    "naicsNationalIndustry": "Pharmaceutical Preparation Manufacturing",
    "naicsSector": "Manufacturing",
    "naicsSubsector": "Chemical Manufacturing",
    "name": "Lipidor AB",
    "phone": "",
    "sedol": "BK5TY21",
    "shareOutstanding": 28.396863,
    "state": "STOCKHOLM",
    "ticker": "LIPI.ST",
    "weburl": "http://www.lipidor.se/"
}